The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A randomized phase II trial of oral vinorelbine as second-line therapy for patients with malignant pleural mesothelioma.
 
Dean Anthony Fennell
Honoraria - Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Inventiva Pharma; Novocure; RS Oncology; targovax
Consulting or Advisory Role - Bristol-Myers Squibb; Inventiva Pharma; Novocure; Roche; Targovax
Speakers' Bureau - BMS; Boehringer Ingelheim
Research Funding - Astex Pharmaceuticals; Bayer; Boehringer Ingelheim (Inst); Fuji Pharma (Inst); lab21 (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; MSD Oncology
 
Angela Claire Casbard
Research Funding - AstraZeneca (Inst); Merck (Inst)
 
Catharine Porter
No Relationships to Disclose
 
Robin Rudd
No Relationships to Disclose
 
Jason Francis Lester
No Relationships to Disclose
 
Marianne Nicolson
Consulting or Advisory Role - Bristol-Myers Squibb
 
Bruno Morgan
No Relationships to Disclose
 
Jeremy Peter Steele
No Relationships to Disclose
 
Liz Darlison
Speakers' Bureau - Bristol-Myers Squibb
 
Georgina Mary Gardner
No Relationships to Disclose
 
Lisette Sheena Nixon
No Relationships to Disclose
 
Terri Kitson
No Relationships to Disclose
 
Ann White
No Relationships to Disclose
 
Gareth Owen Griffiths
Honoraria - AstraZeneca
Research Funding - Astex Pharmaceuticals (Inst); AstraZeneca (Inst); BionTEch (Inst); Bristol-Myers Squibb (Inst); Heartflow (Inst); Jannsenn-Cilag (Inst); Novartis (Inst); Roche (Inst)
 
Charlotte Poile
Research Funding - Boehringer Ingelheim
 
Aarti Gaba
No Relationships to Disclose
 
Sara Busacca
No Relationships to Disclose
 
Catherine Jane Richards
Other Relationship - Amylyx (I); Apellis Pharmaceuticals (I); Biogen (I); Brainstorm Cell Therapeutics (I); Cytokinetics (I); GlaxoSmithKline (I); Lilly (I); Orion (I); Wave Pharmaceuticals (I)